INTRA CELLULAR THERAPIES INC — Form D/A
INTRA CELLULAR THERAPIES INC of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2013-06-25. The offering totals $15.4M, of which $15.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-06-25
- Form: D/A
- Accession: 0001176407-13-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $15.4M
- Amount sold: $15.3M
- Remaining: $110K
- Investors: 12
- Date of first sale: 2012-10-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-194277
Issuer
- Name: INTRA CELLULAR THERAPIES INC
- CIK: 0001176407
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: AUDUBON BIOMEDICAL SCIENCE, NEW YORK, NY, 10032
- Phone: 212-923-3344
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Joel Marcus | Director | South San Francisco, CA |
| Richard Lerner | Director | Baltimore, MD |
| Lawrence Hineline | Executive Officer | New York, NY |
| Sharon Mates | Director | New York, NY |
| Sharon Mates | Executive Officer | New York, NY |
| Lawrence Wennogle | Executive Officer | New York, NY |
| Allen Fienberg | Executive Officer | New York, NY |
| Kimberly Vanover | Executive Officer | New York, NY |
| Michael Rawlins | Director | New York, NY |
| Christopher Alafi | Director | New York, NY |
| Sir Michael J Rawlins | Director | New York, NY |
| Joel J Marcus | Director | Pasadena, CA |
| Richard J Lerner | Director | New York, NY |
| Christopher J Alafi | Director | New York, NY |
| Lawrence J Hineline | Executive Officer | New York, NY |
| David J Kipnis | Director | New York, NY |
Other filings by this issuer (5)
More